30 Women Receive Restored Breasts Using 3D Printed Resorbable Scaffolds

BellaSeno has achieved a significant milestone in regenerative medicine, with 30 women having their breasts restored using innovative 3D printed resorbable scaffolds. These scaffolds are designed to be implanted and then gradually reabsorbed by the body over one to two years, acting as a framework for the patient's own cells to grow and regenerate breast tissue. The polycaprolactone material breaks down completely, leaving behind natural tissue.

The technology allows the scaffolds to be printed with specific structures tailored to individual needs. Once inserted, they are seeded with the patient's own fat, providing a protective structure that facilitates tissue growth and gradually restores breast volume and shape. This approach aims to create a more natural feel and appearance compared to traditional implants, particularly for patients undergoing reconstruction after procedures like mastectomy.

BellaSeno has reported positive outcomes from its clinical trials. The company completed its first trial with 19 patients in 2025 and is currently running a second trial with 11 patients. The announcement of 30 women benefiting from this technology marks a crucial step towards broader clinical application and potential commercialization. BellaSeno anticipates this number to more than double by the end of August as more patients are scheduled for surgery.

Dr. Mohit P. Chhaya, CEO and Co-Founder of BellaSeno, highlighted the company's ambition to advance a new regenerative approach to soft tissue restoration. He emphasized the collaborative effort between scientists, engineers, surgeons, and patients, underscoring the growing role of technologies that harness the body's innate regenerative capabilities. The company is now focusing on the pathway toward commercialization and wider clinical access, suggesting that regenerative soft tissue surgery is transitioning from concept to reality.